Recent Finacing
Recent Raise
Andrus Reo develops a proprietary human reovirus antineoplastic formulation, collaborating with Oncolytics Biotech to advance Phase III trials in Russia/CIS for RAS-activated head-and-neck and pancreatic tumors.
Recent Investors
Funding round
Investor